Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Effectiveness of an Immunobiological Drug in CoViD-19
Phase 2
- Conditions
- COVID-19 PneumoniaCOVID-19 Respiratory InfectionCovid19
- Interventions
- Drug: Anti-SARS-CoV-2Drug: Placebo
- First Posted Date
- 2021-06-04
- Last Posted Date
- 2021-09-17
- Target Recruit Count
- 200
- Registration Number
- NCT04913779
- Locations
- 🇦🇷
Hospital General de Agudos Donación Francisco J. Santojanni, Ciudad Autónoma De Buenos Aires, Argentina
News
No news found